Resource Library
Pamir Strategic Emerging Industry Indicators
On January 20, China’s DeepSeek artificial intelligence (AI) company released its free chatbot, which is based on a large language model (LLM) that is comparable in performance to major non-Chinese LLMs such as OpenAI’s GPT-4, but at a fraction of the cost.
DeepSeek and Its Implications for Opportunities and Risks in China’s AI Market
On January 20, China’s DeepSeek artificial intelligence (AI) company released its free chatbot, which is based on a large language model (LLM) that is comparable in performance to major non-Chinese LLMs such as OpenAI’s GPT-4, but at a fraction of the cost.
China’s Industrial and Technological Developments
On January 20, China’s DeepSeek artificial intelligence (AI) company released its free chatbot, which is based on a large language model (LLM) that is comparable in performance to major non-Chinese LLMs such as OpenAI’s GPT-4, but at a fraction of the cost.
China proposes a draft protocol to ensure that quantum computers cannot crack existing communications encryption security networks
There are international concerns that as quantum computing develops its vast processing power, it could also be used to break existing encryption methods.
Beijing Holds Private Enterprise Symposium, Signaling Support for the Chinese Private Sector
On February 17, 2025, the government of the People’s Republic of China (PRC) convened the latest private enterprise symposium in Beijing.
Chinese breakthrough intensifies global quantum technology race
Chinese scientists recently produced the first-ever, room-temperature time crystal, which has triggered a new round of activities in the US, UK, and European Union to promote development in the field of quantum technology.
IP Theft: Assessing Insider Risk
A Chinese ex-Google software engineer, Linwei Ding, has been arrested for allegedly stealing over 500 sensitive files containing Intellectual Property (IP) about the company’s cutting-edge Machine Learning (ML) platform and the (AI) models it supports.
Generative AI transforming big pharma drug design
Generative AI is transforming the expensive and slow process of drug design and offers the opportunity for the discovery of novel drug compounds.